Stay informed with the latest litigation news. Explore now

IP Verse

Aventis competitive analysis

Latest publications and patents of Aventis New

Explore the latest publications and patents granted to Aventis, showcasing their recent innovations and technological advancements.

Last updated on: Sep 6, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Aventis

EP2493466
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelGranted And Under Opposition
EP3294285
Dec 18, 2019Cabazitaxel And Its Use For Treating CancerRevoked
EP2678011
Jun 26, 2019Antitumoral Combination Comprising Cabazitaxel And CisplatinRevoked

Latest oppositions filed by Aventis

Explore patent oppositions filed by Aventis against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3668568
Dosage Measurement Module On Injection PenELI LILLYMar 7, 2025
EP4017557
Methods And Apparatus For Aspects Of A Dose Detection SystemELI LILLYNov 4, 2024
EP3706841
Needle Shield Remover And A Medicament Delivery Device Comprising The Needle Shield RemoverSHL MEDICALAug 22, 2024
EP3184138
Needle Cover AssemblySHL GROUPJan 12, 2024
EP3666797
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)AMGENNov 10, 2023
EP3740265
A Medicament Delivery Device With A Removable Cap And Locking Member For Preventing Accidental ActiviationCONSORT MEDICALAug 16, 2023
EP3359229
Injector Comprising A Destructible Electric Circuit As A Result Of UseTECPHARMA LICENSINGFeb 16, 2023
EP3071262
Rotary Sensor Assembly With Space Efficient DesignNOVO NORDISKDec 22, 2020
EP3265152
Data Acquisiton Means, Especially For A Pen-Type Drug Delivery DevicesBEREYOct 22, 2020
EP2296728
Administration Device Having A Button With Touch SensorF HOFFMANN LA ROCHEJul 30, 2020

Latest patents of Aventis opposed by its competitors

Explore Aventis's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2493466
Mar 10, 2021Novel Antitumoral Use Of Cabazitaxel13
EP3294285
Dec 18, 2019Cabazitaxel And Its Use For Treating Cancer9
EP2678011
Jun 26, 2019Antitumoral Combination Comprising Cabazitaxel And Cisplatin1

Latest PTAB cases involving Aventis New

Discover the latest PTAB cases involving Aventis, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 12, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Aventis

IPR2023-01045Jun 30, 2023NOVARTIS GENE THERAPIESAVENTISTerminated-Settled
IPR2019-01657Oct 7, 2019MYLAN PHARMACEUTICALSSANFOI AVENTIS DEUTSCHLANDFinal Written Decision
IPR2019-01658Oct 7, 2019MYLAN PHARMACEUTICALSSANOFI AVENTIS DEUTSCHLANDInstitution Denied
IPR2019-00987May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00979May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDFinal Written Decision
IPR2019-00982May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00980May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00981May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-01022May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-01023May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other

Top competitors of Aventis

Top competitors of Aventis based on patent oppositions.